Diabetes

News

Novo enjoys strong Q1 as Trump price crackdown fails to mate...

Novo Nordisk has shaken off fears of a drug pricing crackdown from president Donald Trump, after it beat profit forecasts in Q1 results.

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Boosted by new drugs, Boehringer shrugs off patent expiry

BI boosted by new diabetes and respiratory drugs.

News

AstraZeneca Amenities Building - Mississauga - Sept 2005
Non exclusive, unlimited time license for print & web to WZMH Architects

Real world data will help AZ's Farxiga in cardio battle

AZ hopes data will boost sales of its Farxiga.

News

Pharma attacks plan to ration new drugs in England

Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.

News

Novo Nordisk looking at M&A to revive fortunes, says CEO

Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.

Views & Analysis

The Berlin Declaration – driving early action in type 2 diab...

International initiative helps countries focus on best policies for overcoming diabetes.

Novo enjoys strong Q1 as Trump price crackdown fails to mate...

Boosted by new drugs, Boehringer shrugs off patent expiry

Real world data will help AZ's Farxiga in cardio battle

Pharma attacks plan to ration new drugs in England

Novo Nordisk looking at M&A to revive fortunes, says CEO

The Berlin Declaration – driving early action in type 2 diab...

MSD takes on Pfizer's Prevnar with new Capvaxive approval

Discover a new era of healthcare panel engagement: Grounded ...

Diabetes

Editor's Picks